14:12:47 EST Fri 20 Feb 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Jolt Health Inc (2)
Symbol JOLT
Shares Issued 12,728,754
Close 2026-02-19 C$ 0.125
Market Cap C$ 1,591,094
Recent Sedar+ Documents

Jolt Health changes auditor to Can Partners

2026-02-20 09:15 ET - News Release

Subject: Jolt Press Release - Change of Auditor Feb 2026 Word Document

File: '\\swfile\EmailIn\20260220 044650 Attachment Jolt Press Release - Change of Auditor Feb 2026.docx'

NATDOCS\92221437\V-1

For Immediate Release

JOLT HEALTH INC. ANNOUNCES CHANGE OF AUDITORS

VANCOUVER, BC, CANADA (February 20, 2026) - Jolt Health Inc. ("JOLT" and or "the Company") (CSE:JOLT) (FSE: G1Q0) today announces the appointment Can Partners LLP (the "Successor Auditor"), chartered professional accountants, as the Company's new auditor to hold office until Jolt's next annual meeting of shareholders.

The appointment of the Successor Auditor has been approved by the board of directors (the "Board") and the Company's audit committee (the "Audit Committee"), and Jolt will seek shareholders ratification of the Successor Auditor's appointment at the next annual meeting of shareholders.

The Company's former auditor, Baker Tilly WM LLP (the "Predecessor Auditor"), resigned effective February 17, 2026. The Predecessor Auditor's reports with respect to Jolt's financial statements for the fiscal years ended December 31, 2025 and December 31, 2024 did not contain a modified opinion.

The Company's reporting package, including the notice of change of auditor, together with the required letters from the Predecessor Auditor and Successor Auditor, each prepared in accordance with Section 4.11 of NI 51-102, are available on Jolt's SEDAR+ profile at www.sedarplus.ca.

About Jolt Health Inc.

Jolt Health Inc. (CSE - JOLT) is a leading life sciences company focused on healthcare, biotechnology and artificial intelligence. The company currently holds exclusive licenses for innovative therapeutic and pharmaceutical products throughout Europe, the UK, and North America. The company is committed to transforming the industry through research, collaboration, and technological advancement, sharping the future of healthcare worldwide.

For further information, please contact:

Gerald Tritt, CEO

Investor Relations

Telephone: 1 (604) 343-2977

E-mail: info@jolt-health.com

www.jolt-health.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates", "may" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions, risks relating to epidemics or pandemics such as COVID-19, including the impact of COVID-19 on the Company's business, financial condition and results of operations, lack of investor demand for Bitcoin and/or Bitcoin futures exchange traded funds, and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

© 2026 Canjex Publishing Ltd. All rights reserved.